News for Healthier Living

Children's Hospital Los Angeles Studies New Gene-Editing Approach for Sickle Cell Disease

Children's Hospital Los Angeles is participating in RESTORE, an early-stage clinical trial studying an investigational CRISPR-Cas9 therapy designed to directly modify the beta-globin gene in sickle cell disease.

July 27, 2026


August 7 2026

August 6 2026

August 5 2026

August 4 2026

August 3 2026

August 1 2026

July 31 2026

July 30 2026

July 29 2026

July 28 2026

July 27 2026

July 26 2026